3,4-dihydroxyphenylacetic acid has been researched along with isatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonso, M; Durán, R; Fajardo, D; Faro, LRF; Justo, LA | 1 |
| Alfonso, M; Durán, R; Faro, LRF; Justo, LA | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and isatin
| Article | Year |
|---|---|
Effects and mechanism of action of isatin, a MAO inhibitor, on in vivo striatal dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Female; Isatin; Microdialysis; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley | 2016 |
Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Catechol O-Methyltransferase; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Synergism; Extracellular Space; Female; Homovanillic Acid; Isatin; Male; Microinjections; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley | 2020 |